Скачать или смотреть Transforming the future of healthcare: Do cell and gene therapies hold the key?

While cell and gene therapies are constantly evolving and offer a lot of promise for rare and chronic conditions, they are also surrounded by a range of scientific, logistic and regulatory challenges. There is a clear need for decision-makers and experts to come together to define a sustainable way forward in ensuring safe and affordable access to novel treatments in this space. During this webinar, in partnership with CSL Behring, our multi-stakeholder panel discussed transformative therapies and explored their impact on our health and on the systems that deliver them.

00:00:00​ Introduction
00:02:40 Scene-setting interview
00:18:00 First panel discussion
00:47:30 Second panel discussion
01:24:10 Concluding statement

Speakers:
Bertalan Mesko
Director, The Medical Futurist Institute

Cristian Silviu Bușoi,
MEP, European Parliament

Andrzej Rys
DG SANTE, ​European Commission

Diane Kleinermans
President of the Commission of Drugs Reimbursement, Belgian National Institute for Health and Disability Insurance

Ilona G. Reischl
Quality Assessor - Biologics, Austrian Medicines and Medical Devices Agency (AGES/MEA)

Paige Bischoff
Senior Vice President, Global Public Affairs, Alliance for Regenerative Medicine (ARM)

Dan Hart
Honorary Consultant Haematologist, The Royal London Hospital Haemophilia Centre

Moderation: Vivienne Parry
Science journalist and writer, Head of Engagement, Genomics England